ECCO 2019: Direct and indirect costs of IBD in the biological era

Bobby Zhao Sheng Lo | ECCO 2019 | Mars 11, 2019

Speaker: Bobby Zhao Sheng Lo

Crohn's disease (CD) and ulcerative colitis (UC) carries a high burden on healthcare resources. To date, no study has assessed the combined direct and indirect cost of inflammatory bowel disease (IBD) in a population-based setting. Click and hear the interesting result from a population-based inception cohort with 10 years of follow-up, here presenting by Bobby Zhao Sheng Lo.